Register   |   Login
 
 
 
 
Additional Resources
Multimedia
 
Clinical Trials (RSS)
HCPLive Articles
Through research, a team of scientists have isolated a molecule that can shut down a dysfunctional immune response that causes deadly hemorrhagic shock.
More Stories:
 Videos:
ACTEMRA® (tocilizumab) MOA Video
The video below provides an in-depth look at ACTEMRA and its unique mechanism of action


This video is sponsored by ACTEMRA


Latest News
Events
 
   
 
   

Intellisphere, LLC l 666 Plainsboro Road, Building 300, Plainsboro, NJ 08536 l P 609-716-7777 l F 609-716-4747

Copyright ©MDNG 2006-2010
Intellisphere, LLC
All Rights Reserved